MyVoice:CF is acceptable, appropriate, and usable for those with cystic fibrosis (CF). Among a sample of 43 participants, preliminary effectiveness evaluation suggests that MyVoice:CF improves self-efficacy in and frequency of reproductive health communication.
“Depression is a leading complication during pregnancy with about 15% of patients reporting symptoms at some point in their pregnancy journey,” said lead author Dr. Tamar Krishnamurti. “We already have great screening tools for active depression, but our approach is unique because it predicts who is likely to develop depression in the future. If we can identify people early on, before symptoms emerge, we might be able to tailor preventive care and offer tools and support to address underlying triggers of depression.”
Decentralized biobanking (de-bi) leverages blockchain technology to empower patient engagement in biospecimen research. Dr. Marielle Gross' team demonstrates proof-of-concept for engaging patients, physicians, and scientists in a dynamic research community. This prototype is a first step for advancing paradigm-shifting de-bi technology that provides unprecedented transparency and suggests new standards for equity and inclusion in biobanking.
Dr. Kazmerski , Olivia Stransky, Catherine Wright, Dr. Birru Talabi, Dr. Callegari, Dr. Chang, Dr. Miller, Ashley Deal, Raelynn O'Leary, and Dr. Borrero conducted a study on our femtech tool MyVoice:CF showing that the tool increases self-efficacy and reproductive health communication for those with cystic fibrosis.
Read more about their findings here: https://pubmed.ncbi.nlm.nih.gov/37833123/
Drs. Mosley and Borrero developed a web-based decision aid to support permanent contraception decision called My Decision/Mi Decisión. This tool includes written and video information about tubal sterilization procedures; an interactive table of contraception options; values clarification exercises; reflection and deliberation; knowledge checks; and a summary report to share with one's provider. Users found the decision aid to be informative, engaging, easy to use, and helpful in informing contraception decision making.
Ashley Deal and Raelynn O'Leary's Interaction Design class at CMU collaborated with Dr. Kazmerski and Olivia Stransky to develop mobile tools to help those with Cystic Fibrosis make informed decisions related to breastfeeding/chestfeeding.
Dr. Liz Mosely and her team evaluated an integrated prevention program to address substance use, sexual assault, and sexual risk behaviors in teens called 'Teen Well Check'.
Findings suggest preliminary usability and acceptability.
Read more here: https://www.tandfonline.com/doi/full/10.1080/20008066.2022.2157933
Our team developed a novel patient-facing decision aid to support evidence-based and value-concordant decision making about tubal sterilization among people with Medicaid insurance. Check out our updated webpage and one pager which covers our needs assessment and primary outcomes.
Drs. Lisa Callegari and Sonya Borrero are evaluating MyPath in VA primary care to increase the quality and person-centeredness of reproductive health care delivery in primary care.
Tamar Krishnamurti, PhD received the First in FemTech Award from FemTech Focus! The FemTech movement is built and inspired by leaders like Dr. Krishnamurti and she is being recognized for her showed contributions to women’s health through her excellence in innovation, leadership qualities, milestones accomplished, collaborative spirit, and her dedication to accessibility, affordability, and diversity.
